http://pharmexec.findpharma.com/pharmexec The publisher of Pharmaceutical Executive brings visitors PharmExec.com, which serves up a daily dose of news and features from the world of pharma business and marketing. 2009-11-07T18:46:55Z http://pharmexec.findpharma.com/pharmexec/Applying-FDA-Regulations-to-Online-Marketing---Kli/ArticleStandard/Article/detail/639425?ref=25 Applying FDA Regulations to Online Marketing - Klick Whitepaper 2009-11-04T05:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/452009/639425null PDF http://pharmexec.findpharma.com/pharmexec/News+Analysis/JampJ-Cuts-Staff-in-Major-Restructuring-Move/ArticleStandard/Article/detail/639344?ref=25 Johnson & Johnson announced a massive restructuring plan on Tuesday in an effort to save $1.4 billion to $1.7 billion by 2011. The human cost: 7 percent of its workforce. 2009-11-04T05:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/452009/639344null HTML http://pharmexec.findpharma.com/pharmexec/R%26D/Innovation-Over-Imitation/ArticleStandard/Article/detail/631735?ref=25 As the first generation of biologics patents expire, companies are jokeying for position in follow-on biologics. 2009-11-04T05:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631735/Picture-9_thumbnail.jpg http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631735null XML http://pharmexec.findpharma.com/pharmexec/Deals/Glaxo-Vies-for-a-Second-Act-in-HIV/ArticleStandard/Article/detail/639343?ref=25 A novel joint venture between Glaxo and Pfizer is big on promise. But the combined portfolio and pipeline of HIV drugs? Not so much. 2009-11-04T05:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/452009/639343null HTML http://pharmexec.findpharma.com/pharmexec/Europe+News/Novo-Nordisk-Reports-30-Increased-Operating-Profit/ArticleStandard/Article/detail/638252?ref=25 02 November 2009-11-02T05:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/452009/638252null HTML http://pharmexec.findpharma.com/pharmexec/Europe+Features/Lobbyists-Use-Limp-Sandwiches-to-Shape-the-Pharmac/ArticleStandard/Article/detail/638251?ref=25 Reflector reports on how the European pharma commitees and national associations are trying to shape the upcoming pharmaceutical package through informal 2009-11-02T05:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/452009/638251null HTML http://pharmexec.findpharma.com/pharmexec/Marketing/Sanofi-Warned-for-Misleading-Tent-Card/ArticleStandard/Article/detail/637273?ref=25 Sure, prescription information for Sanofi-Aventis's Uroxatral appears on the back of the tent card, but how can consumer?s see it if it's mounted to a pharmacy wall? 2009-10-28T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/442009/637273null HTML http://pharmexec.findpharma.com/pharmexec/Marketing/Sidewiki-Whats-Pharma-to-Do/ArticleStandard/Article/detail/637271?ref=25 Google opened up a whole new era of social media when it released Sidewiki - a tool that allows anyone to comment on any Web site. Now pharma has a new battle to fight. 2009-10-28T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/442009/637271null HTML http://pharmexec.findpharma.com/pharmexec/News+Analysis/GAO-Accuses-FDA-of-Tardy-Trial-Data/ArticleStandard/Article/detail/637272?ref=25 The US oversight arm scripted a hefty report complaining that FDA is not moving fast enough when it comes to screening clinical trials data for drugs green lit through its expedited approval program. 2009-10-28T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/442009/637272null HTML http://pharmexec.findpharma.com/pharmexec/Europe+News/10000-UK-Cancer-Deaths-Could-be-Avoided/ArticleStandard/Article/detail/637078?ref=25 28 October 2009-10-28T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/442009/637078null HTML http://pharmexec.findpharma.com/pharmexec/Bill-Campbell/ArticleStandard/Article/detail/637398?ref=25 bill Campbell 2009-10-28T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/442009/637398null HTML http://pharmexec.findpharma.com/pharmexec/Europe+News/CROs-United/ArticleStandard/Article/detail/636759?ref=25 US-based CRO, Health Decisions, hopes to raise the efficacy standards for complex studies and help companies get products to market faster by establishing an international network of CROs. 2009-10-27T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/442009/636759null HTML http://pharmexec.findpharma.com/pharmexec/Web+Exclusives/Whats-the-best-managed-pharma-company-Find-out-in-/ArticleStandard/Article/detail/585434?ref=25 Industry Audit and Company of The year. 2009-10-21T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/102009/585434null HTML http://pharmexec.findpharma.com/pharmexec/Whitepaper/Professional-Scientific-StaffingsupSMsup-Solutions/ArticleStandard/Article/detail/635609?ref=25 Lancaster Laboratories? Professional Scientific StaffingSM service has been specifically designed to give you the ?non-permanent? workforce you need for anywhere from one year to 10 years or more with no worries about co-employment and at lower costs than fixed headcounts. 2009-10-21T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/432009/635609null REMOTE http://pharmexec.findpharma.com/pharmexec/Europe+News/UKs-NICE-Rejects-GSK-Breast-Cancer-Treatment/ArticleStandard/Article/detail/635531?ref=25 21 October 2009-10-21T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/432009/635531null HTML http://pharmexec.findpharma.com/pharmexec/Pfizer-Profits-Spike-as-Wyeth-Deal-is-Finalized/ArticleStandard/Article/detail/635627?ref=25 The third quarter reports are in, and Pfizer's profits are up but sales are down. The company is compensating for looming patent expirations with layoffs and restructuring; is it enough to boost sales? 2009-10-21T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/432009/635627null HTML http://pharmexec.findpharma.com/pharmexec/Emerging-Pharma-Leadership-Awards---Elizabeth-Muti/ArticleStandard/Article/detail/635010?ref=25 2009-10-19T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/432009/635010null HTML http://pharmexec.findpharma.com/pharmexec/Web+Exclusives/Pharmas-Emerging-Leaders---Podcast-series/ArticleStandard/Article/detail/635039?ref=25 Pharm Exec interviews some of this year's emerging leaders to learn their strategies for success. 2009-10-19T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/432009/635039/emergingleader_thumbnail.jpg http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/432009/635039null HTML http://pharmexec.findpharma.com/pharmexec/Professional-Scientific-StaffingSM-Solutions---Lan/ArticleStandard/Article/detail/635079?ref=25 Professional Scientific StaffingSM Solutions - Lancaster Whitepaper 2009-10-19T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/432009/635079null PDF http://pharmexec.findpharma.com/pharmexec/Emerging-Pharma-Leadership-Awards---Michelle-Dipp/ArticleStandard/Article/detail/635017?ref=25 2009-10-19T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/432009/635017null HTML http://pharmexec.findpharma.com/pharmexec/Europe+Features/Cegedim-Talks-CRM/ArticleStandard/Article/detail/634941?ref=25 Cegedim CEO Laurent Labrune talks to Pharm Exec Europe about how the company is maintaining its CRM lead in a rapidly changing industry. 2009-10-19T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/432009/634941/laurentlabrune_DSF0016_main.jpg http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/432009/634941null HTML http://pharmexec.findpharma.com/pharmexec/Europe+News/Switzerlands-Medicines-for-Malaria-Receives-Gates-/ArticleStandard/Article/detail/634872?ref=25 19 October 2009-10-19T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/432009/634872null HTML http://pharmexec.findpharma.com/pharmexec/Emerging-Pharma-Leadership-Awards---Kathryn-Metcal/ArticleStandard/Article/detail/635013?ref=25 2009-10-19T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/432009/635013null HTML http://pharmexec.findpharma.com/pharmexec/Emerging-Pharma-Leadership-Awards---Luca-Santarell/ArticleStandard/Article/detail/635007?ref=25 2009-10-19T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/432009/635007null HTML http://pharmexec.findpharma.com/pharmexec/Emerging-Pharma-Leadership-Awards---Carrolee-Barlo/ArticleStandard/Article/detail/634501?ref=25 2009-10-15T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/422009/634501null HTML http://pharmexec.findpharma.com/pharmexec/Technology/Listen-to-a-preview-of-Drugs-Devices-or-Data---Whi/ArticleStandard/Article/detail/634361?ref=25 2009-10-15T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/422009/634361null HTML http://pharmexec.findpharma.com/pharmexec/Emerging-Pharma-Leadership-Awards---Joe-Shields/ArticleStandard/Article/detail/634505?ref=25 2009-10-15T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/422009/634505null HTML http://pharmexec.findpharma.com/pharmexec/Emerging-Leadsership-Pharma-Awards---Virginia-carn/ArticleStandard/Article/detail/634468?ref=25 2009-10-15T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/422009/634468null HTML http://pharmexec.findpharma.com/pharmexec/Emerging-Pharma-Leadership-Awards---Scott-Cormack/ArticleStandard/Article/detail/634506?ref=25 2009-10-15T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/422009/634506null HTML http://pharmexec.findpharma.com/pharmexec/Emerging-Leadsership-Pharma-Awards---Paulash-Mohse/ArticleStandard/Article/detail/634467?ref=25 2009-10-15T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/422009/634467null HTML http://pharmexec.findpharma.com/pharmexec/Emerging-Pharma-Leadership-Awards---Jennifer-Smith/ArticleStandard/Article/detail/634497?ref=25 2009-10-15T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/422009/634497null HTML http://pharmexec.findpharma.com/pharmexec/News+Analysis/Jury-Sides-with-Family-in-Paxil-Birth-Defect-Case/ArticleStandard/Article/detail/634103?ref=25 GSK is being ordered to pay $2.5 million in restitution to a Pennsylvania family. The firm was accused of not doing enough to warn consumers that taking the antidepressant Paxil, while pregnant, could lead to birth defects. 2009-10-14T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/422009/634103null HTML http://pharmexec.findpharma.com/pharmexec/News+Analysis/Sandoz-and-Shire-settle-Adderall-XR-Dispute/ArticleStandard/Article/detail/634102?ref=25 Sandoz Shire Pharmaceuticals announced that it would allow Sandoz to market a generic version of its blockbuster ADHD med Adderall XR if it can clear FDA. But that's a big if. 2009-10-14T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/422009/634102null HTML http://pharmexec.findpharma.com/pharmexec/Emerging-Leadership-Pharma-Awards--Frank-Karbe/ArticleStandard/Article/detail/634174?ref=25 2009-10-14T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/422009/634174null HTML http://pharmexec.findpharma.com/pharmexec/Technology/Cut-the-Cord-and-Take-to-the-Cloud/ArticleStandard/Article/detail/634082?ref=25 One feature that should be considered when looking for a new software-as-a-service (SaaS) system is multi-tenancy, which is a chief characteristic of a mature cloud computing application. Here?s what to look for. 2009-10-14T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/422009/634082null HTML http://pharmexec.findpharma.com/pharmexec/Legislation/Action-Amid-Uncertainty-Preparing-for-Health-Refor/ArticleStandard/Article/detail/634083?ref=25 As the health care reform debate continues to rage on Capitol Hill, pharma companies should be engaged in intense strategic planning for the future. Putting together a game plan now for the most likely reform scenarios will help companies to stay ahead of the curve. 2009-10-14T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/422009/634083null HTML http://pharmexec.findpharma.com/pharmexec/R%26D/Biomarkers-Promises-and-Challenges/ArticleStandard/Article/detail/634081?ref=25 Jerome Wilson and Martin Nemansky, explore some of the difficulties of implementing biomarkers during drug development. 2009-10-14T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/422009/634081null HTML http://pharmexec.findpharma.com/pharmexec/Europe+News/Economist-Award-for-Bioscience-Announced/ArticleStandard/Article/detail/633542?ref=25 13 October 2009-10-13T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/422009/633542null HTML http://pharmexec.findpharma.com/pharmexec/Europe+News/RA-Treatment-Uneven-Across-Europe/ArticleStandard/Article/detail/633347?ref=25 12 October 2009-10-12T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/422009/633347null HTML http://pharmexec.findpharma.com/pharmexec/Strategy/Global-Pharma-Market-Growth-to-Grow-4-to-6-Percent/ArticleStandard/Article/detail/632250?ref=25 Sure, industry growth is at "historically low levels," but at least pharma is still growing. The industry's market value should surpass $825 billion in 2010, and forecasted growth was bumped up one percentage point from original estimates. 2009-10-08T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/632250null HTML http://pharmexec.findpharma.com/pharmexec/Meet-Pharm-Execs-2009-Emerging/ArticleStandard/Article/detail/632759?ref=25 Meet Pharm Exec?s 2009 Emerging Leaders?27 industry pioneers under age 45 who are bringing new ideas to life - 09 emerging leaders 2009-10-08T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/632759null PDF http://pharmexec.findpharma.com/pharmexec/News+Analysis/H1N1-Vaccine-Hits-the-Market/ArticleStandard/Article/detail/632251?ref=25 Pulling off an incredibly fast turnaround, the pharma industry has released a vaccine for the H1N1 virus, bolstering its bottom line with a second flu vaccine and potentially helping millions of people. So why is there such an uproar over whether it's safe? 2009-10-07T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/632251null HTML http://pharmexec.findpharma.com/pharmexec/Sales/The-Changing-Pharmaceutical-Sales-Landscape/ArticleStandard/Article/detail/632252?ref=25 Sales forces can achieve compliance and excellence through individual behavioral fine-tuning and company-wide cultural adjustment. 2009-10-07T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/632252null HTML http://pharmexec.findpharma.com/pharmexec/Europe+News/Sandoz-Launches-First-Biosimilar-in-Japan/ArticleStandard/Article/detail/631745?ref=25 06 October 2009-10-06T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631745null HTML http://pharmexec.findpharma.com/pharmexec/Europe+Features/Why-Use-a-Clinical-Data-Warehouse/ArticleStandard/Article/detail/630131?ref=25 An increasing pressure to get products to market means more data must be handled within a shorter time span. But how? 2009-10-06T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/402009/630131null HTML http://pharmexec.findpharma.com/pharmexec/Europe+Features/Cellectis-French-Biotech-Without-Tears/ArticleStandard/Article/detail/631223?ref=25 Pharm Exec Europe speaks to Cellectis CEO André Choulika about the biotech company's ongoing success and the advantages of being based in France. 2009-10-06T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631223null HTML http://pharmexec.findpharma.com/pharmexec/Europe+News/Takeda-Targets-Most-Promising-Markets/ArticleStandard/Article/detail/631226?ref=25 05 October 2009-10-05T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631226null HTML http://pharmexec.findpharma.com/pharmexec/Popular+Articles/The-Difficult-Art-of-Budgeting-for-Translation/ArticleStandard/Article/detail/636934?ref=25 What you need to know in order to budget right and for less money 2009-10-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/442009/636934null XML http://pharmexec.findpharma.com/pharmexec/Popular+Articles/Key-Strategies-for-Planning-and-Executing-Successf/ArticleStandard/Article/detail/636935?ref=25 The most imporant thing to remember when planning a global clinical trial is very basic and almost always overlooked 2009-10-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/442009/636935null XML http://pharmexec.findpharma.com/pharmexec/R%26D/Finding-the-Sweet-Spot/ArticleStandard/Article/detail/631734?ref=25 How proper site activation and site enrollment can help you get the most from clinical trials. 2009-10-02T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631734/Picture-10_thumbnail.jpg http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631734null XML http://pharmexec.findpharma.com/pharmexec/Europe+News/Biotech-Uneven-in-EU-Member-States/ArticleStandard/Article/detail/631115?ref=25 02 October 2009-10-02T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/402009/631115null HTML http://pharmexec.findpharma.com/pharmexec/Think-Different/ArticleStandard/Article/detail/631736?ref=25 Game-changers can create competitive advantages for pharmaceutical companies and products. 2009-10-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631736null XML http://pharmexec.findpharma.com/pharmexec/Back+Page/Animal-Testing-Terrorism-and-the-Militant-Fringe/ArticleStandard/Article/detail/631732?ref=25 The militant fringe of animal rights activists targets pharma. 2009-10-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631732null XML http://pharmexec.findpharma.com/pharmexec/Washington+Report/Science-and-Safety/ArticleStandard/Article/detail/631740?ref=25 All the focus on drug safety raises concerns about FDA delays in approving new drugs for market. 2009-10-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631740null XML http://pharmexec.findpharma.com/pharmexec/Marketing/Making-Big-Waves/ArticleStandard/Article/detail/631733?ref=25 How a small competitor benefited from the use of interactive marketing. 2009-10-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631733null XML http://pharmexec.findpharma.com/pharmexec/Strategy/Are-You-Ready-For-The-Revolution/ArticleStandard/Article/detail/631737?ref=25 Seven Global Trends shaping the future of the pharmaceutical industry. 2009-10-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631737/Picture-11_thumbnail.jpg http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631737null XML http://pharmexec.findpharma.com/pharmexec/Marketing/Innovation-By-Design/ArticleStandard/Article/detail/631738?ref=25 Executives should embrace design to discover new markets and find new ways to server customers. 2009-10-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631738null XML http://pharmexec.findpharma.com/pharmexec/Strategy/The-Book-on-Daniel/ArticleStandard/Article/detail/631739?ref=25 Novartis CEO Daniel Vasella has built the Swiss firm into the fastest growing pharma in the world, and in the process gained a reputation as an outspoken visionary. But is he really as good as all that? 2009-10-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631739/Picture-12_thumbnail.jpg http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631739null XML http://pharmexec.findpharma.com/pharmexec/Europe+News/Sanofi-Acquires-Fovea-in-370M-Deal/ArticleStandard/Article/detail/630595?ref=25 01 October 2009 2009-10-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/402009/630595null HTML http://pharmexec.findpharma.com/pharmexec/Leadership+Column/End-the-Hard-Stop/ArticleStandard/Article/detail/631730?ref=25 Leaders manage their time and focus their resources by limiting unwanted interruptions. 2009-10-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631730null XML http://pharmexec.findpharma.com/pharmexec/From+the+Editor/Explaining-Innovation/ArticleStandard/Article/detail/631731?ref=25 Governments and payers don't see that innovation covers everything from invention to building market share. Scant attention is paid to the critical "back end" of the innovation cycle. 2009-10-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631731null XML http://pharmexec.findpharma.com/pharmexec/Europe+News/Almac-Plans-500-New-Jobs-for-Northern-Ireland/ArticleStandard/Article/detail/630142?ref=25 30 September 2009 2009-09-30T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/402009/630142null HTML http://pharmexec.findpharma.com/pharmexec/News+Analysis/iPharm-Execi-QampA-GSKs-Deirdre-Connelly/ArticleStandard/Article/detail/630329?ref=25 Just months on the job and GSK’s new president of North American Pharmaceuticals Deirdre Connelly is already making her presence known. Her latest move—spearheading an initiative that will boost funding to autonomous CME programs and cut commercial medical education programs. Pharm Exec spoke with Connelly to find out more. 2009-09-30T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/402009/630329null HTML http://pharmexec.findpharma.com/pharmexec/Marketing/Pharma-Targeted-Brandjacking-on-the-Rise/ArticleStandard/Article/detail/630327?ref=25 Illegal online pharmacies are on the rise, brandjacking dozens of big name pharmaceuticals and netting almost $11 billion in sales this year alone. With consumers on the hunt for affordable meds, the trend is only going to get worse. 2009-09-30T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/402009/630327null HTML http://pharmexec.findpharma.com/pharmexec/2010-PharmExec-Media-Kit/ArticleStandard/Article/detail/629821?ref=25 2010 PharmExec Media Kit 2009-09-29T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/402009/629821null PDF http://pharmexec.findpharma.com/pharmexec/June-09-BPA-Statement/ArticleStandard/Article/detail/629822?ref=25 June 2009 BPA Statement 2009-09-29T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/402009/629822null PDF http://pharmexec.findpharma.com/pharmexec/Prixgalien2009/Pro-Bono-Humanum-Award-Barry-Bloom-Harvard-School-/ArticleStandard/Article/detail/631988?ref=25 2009-09-28T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631988null HTML http://pharmexec.findpharma.com/pharmexec/Prixgalien2009/Best-biotech-1Amgen-Nplate/ArticleStandard/Article/detail/631790?ref=25 2009-09-28T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631790null HTML http://pharmexec.findpharma.com/pharmexec/Prixgalien2009/Best-pharma-productNovartisGLEEVEC/ArticleStandard/Article/detail/631490?ref=25 2009-09-28T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631490null HTML http://pharmexec.findpharma.com/pharmexec/Prixgalien2009/Best-Medical-Product--Cell-search-Veridex/ArticleStandard/Article/detail/631951?ref=25 2009-09-28T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631951null HTML http://pharmexec.findpharma.com/pharmexec/Prixgalien2009/Oracles-Neil-de-Crescenzo-talks-about-innovation/ArticleStandard/Article/detail/633396?ref=25 2009-09-28T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/422009/633396null HTML http://pharmexec.findpharma.com/pharmexec/Prixgalien2009/Best-biotech-2PROMACTA-GSK/ArticleStandard/Article/detail/631945?ref=25 2009-09-28T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631945null HTML http://pharmexec.findpharma.com/pharmexec/Prixgalien2009/Pro-Bono-Humanum-Award-Jeffrey-SachsDirector-of-Th/ArticleStandard/Article/detail/631966?ref=25 2009-09-28T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/412009/631966null HTML http://pharmexec.findpharma.com/pharmexec/2009-Industry-Audit/ArticleStandard/Article/detail/628807?ref=25 2009 Industry Audit 2009-09-23T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/392009/628807null PDF http://pharmexec.findpharma.com/pharmexec/Europe+Features/Takeda-takes-on-Europe/ArticleStandard/Article/detail/626813?ref=25 Takeda's Dr Erich Brunn tells Pharm Exec Europe why now is the right time for the Japanese giant to get really serious about Europe. 2009-09-22T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/382009/626813null HTML http://pharmexec.findpharma.com/pharmexec/Europe+Features/A-New-Approach-to-Managing-Safety-Information-in-C/ArticleStandard/Article/detail/626961?ref=25 Clinical trials are conducted to prove the efficacy and safety of drugs, so why, Michael Reynolds asks, is so much emphasis is still centred just on efficacy? 2009-09-22T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/382009/626961null HTML http://pharmexec.findpharma.com/pharmexec/Europe+Features/What-does-the-multi-channel-enabled-pharma-company/ArticleStandard/Article/detail/627592?ref=25 "If you don't like change, you are going to like irrelevance even less." Gen Eric Shinseki US Army (ret.) 2009-09-18T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/382009/627592null HTML http://pharmexec.findpharma.com/pharmexec/Europe+News/Helsinn-and-Eisai-Italy-in-licensing-agreement/ArticleStandard/Article/detail/626804?ref=25 16 September 2009 2009-09-16T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/382009/626804null HTML http://pharmexec.findpharma.com/pharmexec/Europe+Features/What-pharma-can-learn-from-general-manufacturing-i/ArticleStandard/Article/detail/626802?ref=25 While pharma is not synchronized with the boom and bust of the general economy, lessons from the business cycle facing manufacturers can enable the pharmaceutical industry to tackle the problems it faces, writes Chris Hart of McKinney Rogers. 2009-09-16T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/382009/626802null HTML http://pharmexec.findpharma.com/pharmexec/News+Analysis/JampJ-Slims-Down-Elan-Offer-sans-Tysabri/ArticleStandard/Article/detail/626746?ref=25 Elan was forced to trim $100 million off its billion-dollar deal with J&J due to a 50/50 agreement with Biogen Idec involving co-ownership of MS drug Tysabri. Now J&J is out a major drug, Elan is out a good chunk of cash, and Biogen Idec is pondering its next move. 2009-09-16T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/382009/626746null HTML http://pharmexec.findpharma.com/pharmexec/Europe+News/IMI-Announces-Next-Topics-for-Research/ArticleStandard/Article/detail/626551?ref=25 15 September 2009 2009-09-15T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/382009/626551null HTML http://pharmexec.findpharma.com/pharmexec/News+Analysis/Lilly-Shuffles-Staff-Cuts-Thousands-of-Jobs/ArticleStandard/Article/detail/626469?ref=25 Eli Lilly announced this morning that it would eliminate approximately 5,500 positions as part of a massive reorganization strategy that's expected to net the firm reduce $1 billion in costs by 2011. 2009-09-14T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/382009/626469null HTML http://pharmexec.findpharma.com/pharmexec/Europe+News/AstraZeneca-wins-over-UK-doctors/ArticleStandard/Article/detail/625465?ref=25 10 September 2009 2009-09-10T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/372009/625465null HTML http://pharmexec.findpharma.com/pharmexec/PodcastThe-Future-of-Oncology/ArticleStandard/Article/detail/625168?ref=25 2009-09-09T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/372009/625168null HTML http://pharmexec.findpharma.com/pharmexec/Careers%3A+News+and+Articles/Successful-Product-Managers-Handbook/ArticleStandard/Article/detail/625161?ref=25 2009-09-09T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/372009/625161null REMOTE http://pharmexec.findpharma.com/pharmexec/News+Analysis/Roche-Shifts-Execs-in-Anticipation-of-Departures/ArticleStandard/Article/detail/625139?ref=25 With the pending retirement of three senior-level executives, Roche announced a new corporate executive team to bridge the personnel gap while the company looks for new leaders. 2009-09-09T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/372009/625139null HTML http://pharmexec.findpharma.com/pharmexec/Global+Report/UK-Pharmacies-Dealing-with-Drug-Shortages/ArticleStandard/Article/detail/625140?ref=25 With a weak pound being outpaced by the euro, many hospitals are sending drugs to the Continent for higher profits. What can NHS do to stop this practice? 2009-09-09T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/372009/625140null HTML http://pharmexec.findpharma.com/pharmexec/News+Analysis/Sepracor-Faces-Shareholder-Lawsuit-in-Wake-of-26B-/ArticleStandard/Article/detail/625138?ref=25 Some shareholders think they were shafted in the multi-billion dollar deal between Sepracor and Dainippon Sumitomo Pharma. They're so miffed, in fact, that they've filed a lawsuit stating that the amount offered undervalues the company and its shares. 2009-09-09T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/372009/625138null HTML http://pharmexec.findpharma.com/pharmexec/Europe+Features/Meeting-the-Physician-Spend-Management-Challenge/ArticleStandard/Article/detail/623510?ref=25 Ravi Shankar asks how pharmaceutical firms can best organise the vast amounts of data needed to stay in compliance with issues such as physician spend management. 2009-09-08T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/362009/623510null HTML http://pharmexec.findpharma.com/pharmexec/Whitepaper/Physician-Spend-Management-How-Health-and-Life-Sci/ArticleStandard/Article/detail/624612?ref=25 Many state-level governments have adopted legislations that limit as well as mandate the disclosure of payments to physicians. 2009-09-08T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/372009/624612null REMOTE http://pharmexec.findpharma.com/pharmexec/Europe+Features/The-New-Hot-Topics-in-Supply-Chain-Management/ArticleStandard/Article/detail/623509?ref=25 Times are changing in the pharmaceutical and life sciences sectors and their supply chains are having to adapt to a new set of challenges, says Kenneth Porter of specialist consultancy Total Logistics. 2009-09-08T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/362009/623509null HTML http://pharmexec.findpharma.com/pharmexec/Europe+News/Algeta-amp-Bayer-in-cancer-drug-deal/ArticleStandard/Article/detail/623829?ref=25 3rd September 2009 2009-09-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/362009/623829null HTML http://pharmexec.findpharma.com/pharmexec/Two-Views-From-Inside-The-Exhibition-Booth/ArticleStandard/Article/detail/625753?ref=25 No longer just a meet-and-greet venue, the exhibition booth has become an effective selling channel 2009-09-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/372009/625753null XML http://pharmexec.findpharma.com/pharmexec/Physician-Spend-Management-How-Health-and-Life-Sci/ArticleStandard/Article/detail/623828?ref=25 Physician Spend Management: How Health and Life Sciences Companies Can Simplify Compliance with Master Data Management - Siperian Whitepaper 2009-09-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/362009/623828null PDF http://pharmexec.findpharma.com/pharmexec/Physician-Meetings-A-Bright-Future/ArticleStandard/Article/detail/625749?ref=25 The good news is that as the industry changes its sales force model, the need for meetings will increase 2009-09-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/372009/625749null XML http://pharmexec.findpharma.com/pharmexec/Physician-Spend-Management-How-Health-and-Life-Sci/ArticleStandard/Article/detail/624050?ref=25 Physician Spend Management: How Health and Life Sciences Companies Can Simplify Compliance with Master Data Management - Siperian Whitepaper 2009-09-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/362009/624050null PDF http://pharmexec.findpharma.com/pharmexec/Perception-is-Reality/ArticleStandard/Article/detail/625751?ref=25 In this day and age of regulations and austerity, upscale venues are no longer able to put on the ritz 2009-09-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/372009/625751null XML http://pharmexec.findpharma.com/pharmexec/Information-Education-and-Talk-Trump-Free-Pens/ArticleStandard/Article/detail/625750?ref=25 Exhibit marketers can breath a sigh of relief to find out that the new code is having little impact on attendance 2009-09-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/372009/625750null XML http://pharmexec.findpharma.com/pharmexec/The-Shrinking-Pool/ArticleStandard/Article/detail/625752?ref=25 Public scrutiny, regulations, and pharma's image are taking a toll on the availability of KOLs 2009-09-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/372009/625752null XML http://pharmexec.findpharma.com/pharmexec/Europe+News/Global-Cancer-Cases-to-Grow-by-30-Per-Cent/ArticleStandard/Article/detail/623601?ref=25 2 September 2009 2009-09-02T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/362009/623601null HTML